Biotechnology and Software Patent Law
Show Less

Biotechnology and Software Patent Law

A Comparative Review of New Developments

Edited by Emanuela Arezzo and Gustavo Ghidini

The new millennium has carried several challenges for patent law. This up-to-date book provides readers with an important overview of the most critical issues patent law is still facing today at the beginning of the twenty first century, on both sides of the Atlantic.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 10: Gene Patents Under Fire: Weighing the Costs and Benefits

Christopher M. Holman


Christopher M. Holman INTRODUCTION In 1980, the US Supreme Court helped jumpstart a fledgling biotechnology industry with its landmark decision in the case of Diamond v. Chakrabarty.1 At issue was the ‘patent eligibility’ of a non-naturally occurring, genetically engineered micro-organism.2 Dr. Chakrabarty’s invention was a bacterium he had modified in the laboratory by the introduction of genetic material encoding enzymes capable of metabolizing crude oil, thereby (in principle) conferring upon the bacterium the ability to break down an oil spill.3 The United States Patent and Trademark Office (PTO) had rejected a claim directed towards the bacterium, asserting that a living organism is not patent eligible, notwithstanding the fact that the organism is ‘man-made’ and satisfies all the other statutory requirements of patentability, such as novelty, nonobviousness and practical utility. In a close 5–4 decision, the Court decided in favor of a patent eligibility not only for Dr. Chakrabarty’s genetically engineered bacterium, but by implication generally for genetically engineered organisms and other products of biotechnology created using naturally occurring biological Diamond v. Chakrabarty, 447 U.S. 303 (1980). 35 USC 101 is the source of the so-called ‘patent eligibility’ doctrine, which requires a patent claim to encompass only subject matter that is ‘patent eligible’. It is a threshold requirement of patentability; a patent claim is invalid if it covers subject matter that is patent ineligible. See Chakrabarty, supra note 1; Bilski v. Kappos, 130 S.Ct. 3218(2010). The terms ‘patentable subject matter’ and ‘patent eligibility’ are used interchangeably to describe this...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.